UBS Group’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.4M | Sell |
|
|||||
|
2025
Q1 | $57M | Sell |
|
|||||
|
2024
Q4 | $67M | Buy |
|
|||||
|
2024
Q3 | $6.73M | Buy |
|
|||||
|
2024
Q2 | $7.28M | Sell |
|
|||||
|
2024
Q1 | $7.45M | Buy |
|
|||||
|
2023
Q4 | $8.08M | Buy |
|
|||||
|
2023
Q3 | $4.95M | Buy |
|
|||||
|
2023
Q2 | $3.81M | Sell |
|
|||||
|
2023
Q1 | $3.61M | Sell |
|
|||||
|
2022
Q4 | $6.1M | Buy |
|
|||||
|
2022
Q3 | $2.71M | Sell |
|
|||||
|
2022
Q2 | $6.3M | Sell |
|
|||||
|
2022
Q1 | $7.45M | Buy |
|
|||||
|
2021
Q4 | $5.89M | Buy |
|
|||||
|
2021
Q3 | $4.46M | Sell |
|
|||||
|
2021
Q2 | $6.19M | Buy |
|
|||||
|
2021
Q1 | $1.31M | Sell |
|
|||||
|
2020
Q4 | $4.09M | Sell |
|
|||||
|
2020
Q3 | $5.17M | Buy |
|
|||||
|
2020
Q2 | $2.87M | Sell |
|
|||||
|
2020
Q1 | $4.31M | Sell |
|
|||||
|
2019
Q4 | $8.97M | Sell |
|
|||||
|
2019
Q3 | $13.7M | Buy |
|
|||||
|
2019
Q2 | $9.35M | Buy |
|
|||||
|
2019
Q1 | $8.5M | Sell |
|
|||||
|
2018
Q4 | $9.34M | Buy |
|
|||||
|
2018
Q3 | $5.33M | Buy |
|
|||||
|
2018
Q2 | $3.27M | Sell |
|
|||||
|
2018
Q1 | $8M | Buy |
|
|||||
|
2017
Q4 | $4.54M | Sell |
|
|||||
|
2017
Q3 | $6.12M | Buy |
|
|||||
|
2017
Q2 | $3.46M | Sell |
|
|||||
|
2017
Q1 | $4.3M | Sell |
|
|||||
|
2016
Q4 | $6.1M | Sell |
|
|||||
|
2016
Q3 | $5.76M | Buy |
|
|||||
|
2016
Q2 | $1.69M | Sell |
|
|||||
|
2016
Q1 | $3.45M | Sell |
|
|||||
|
2015
Q4 | $10.8M | Buy |
|
|||||
|
2015
Q3 | $3.75M | Sell |
|
|||||
|
2015
Q2 | $6.76M | Buy |
|
|||||
|
2015
Q1 | $5.45M | Sell |
|
|||||
|
2014
Q4 | $6.25M | Buy |
|